Analysis of DNA Methylation in Plasma for Monitoring Hepatocarcinogenesis-Reference-Cited by-同舟云学术

Analysis of DNA Methylation in Plasma for Monitoring Hepatocarcinogenesis

Published:2015-06 Issue:6 Volume:19 Page:295-302
ISSN:1945-0265
Container-title:Genetic Testing and Molecular Biomarkers
language:en
Short-container-title:Genetic Testing and Molecular Biomarkers

Author:

Huang Wenqing¹,Li Tong²,Yang Wenli¹,Chai Xinjuan¹,Chen Kefei³,Wei Ling¹,Duan Shuwang¹,Li Bo³,Qin Yang¹

Affiliation:

1. Department of Biochemistry and Molecular Biology, School of Preclinical and Forensic Medicine, West China Medical Center, Sichuan University, Chengdu, China.

2. Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.

3. Division of Liver Transplantation, Department of Surgery, West China Hospital, Chengdu, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical),General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/gtmb.2014.0292

Reference42 articles.

1. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma

2. Non-Invasive Markers of Liver Fibrosis in HCV Mono-Infected and in HIV/HCV Co-Infected Subjects

3. Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma

4. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients

5. BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

2. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis;PeerJ;2022-11-03

3. The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma;Journal of Clinical Medicine;2022-08-21

4. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?;Cancers;2021-05-10

5. Diagnostic performance of circulating cell-free DNA for hepatocellular carcinoma: a systematic review and meta-analysis;Biomarkers in Medicine;2021-02